{"DataElement":{"publicId":"2722674","version":"3.1","preferredName":"Histology Nottingham Score Mitosis Evaluation Percentage Value","preferredDefinition":"the value, as a percentage, of cell division in tumor cells observed reported using the Nottingham Prognostic Index for grade of breast cancer.","longName":"HIS_NS_MIT_EVA_P_VAL","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2009677","version":"3","preferredName":"Histology Nottingham Score Mitosis Evaluation","preferredDefinition":"related to the outcome from observing the microscopic process of cell division in tumor cells as part of criteria from the Nottingham Prognostic Index to determine the grade of breast cancer.","longName":"HIST_NS_MITOS_ASSESS","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2722641","version":"1","preferredName":"Histology Nottingham Score","preferredDefinition":"The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains.:The numerical result of analysis of a breast cancer based on the Nottingham Prognostic Index.","longName":"C16681:C25595","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Histology","conceptCode":"C16681","definition":"The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Nottingham Score","conceptCode":"C25595","definition":"A numeric representation combining three histologic reporting elements, tubule formation, nuclear pleomorphism and mitotic count, to determine the grade of breast cancer. The Nottingham Score is a factor in determining the Nottingham Prognostic Index.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"44017AE6-67BC-16E4-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-01-18","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-01-18","modifiedBy":"ONEDATA","dateModified":"2008-01-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2722642","version":"1","preferredName":"Mitosis Evaluation","preferredDefinition":"The usual process of somatic reproduction of cells consisting of a sequence of modifications of the nucleus that result in the formation of two daughter cells with exactly the same chromosome and DNA content as that of the original cell. It is the process by which the body grows and replaces cells and is divided into four phases. In Prophase, paired chromosomes form, nuclear membrane disappears, the achromatic spindle appears, and polar bodies form. In Metaphase, chromosomes are arranged in the equatorial plane of the central spindle to form the monaster and chromosomes separate into exactly similar halves. In Anaphase, the two groups of daughter chromosomes separate and move along the fibers of the central spindle, each toward one of the asters, forming the diaster. In Telophase, the daughter chromosomes resolve themselves into a reticulum, the daughter nuclei are formed, and the cytoplasm divides forming two complete daughter cells.:Evaluation; the act of placing value on something.","longName":"C16864:C25214","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mitosis","conceptCode":"C16864","definition":"The usual process of somatic reproduction of cells consisting of a sequence of modifications of the nucleus that result in the formation of two daughter cells with exactly the same chromosome and DNA content as that of the original cell. It is the process by which the body grows and replaces cells and is divided into four phases. In Prophase, paired chromosomes form, nuclear membrane disappears, the achromatic spindle appears, and polar bodies form. In Metaphase, chromosomes are arranged in the equatorial plane of the central spindle to form the monaster and chromosomes separate into exactly similar halves. In Anaphase, the two groups of daughter chromosomes separate and move along the fibers of the central spindle, each toward one of the asters, forming the diaster. In Telophase, the daughter chromosomes resolve themselves into a reticulum, the daughter nuclei are formed, and the cytoplasm divides forming two complete daughter cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Evaluation","conceptCode":"C25214","definition":"Systematic, objective appraisal of the significance, effectiveness, and impact of activities or condition according to specified objectives and criteria.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"44017AE6-67CD-16E4-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-01-18","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-01-18","modifiedBy":"ONEDATA","dateModified":"2008-01-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"17EEDB15-9CF2-2DFB-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-07-06","endDate":null,"createdBy":"PWEST","dateCreated":"2006-07-06","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"updated for ISO compliance","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2181247","version":"1","preferredName":"Cell Percentage Value","preferredDefinition":"information related to the percentage value for a cell count.","longName":"CELL_PTG_VAL","context":"CTEP","contextVersion":"2.31","type":"Non-enumerated","dataType":"NUMBER","minLength":"1","maxLength":"3","minValue":null,"maxValue":null,"decimalPlace":"0","format":"%","PermissibleValues":[],"ConceptualDomain":{"publicId":"2008541","version":"1","preferredName":"Numbers","preferredDefinition":"the set of non-negative integers.","longName":"NUMS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B227CE66-2830-4A7B-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2208119","version":"1","preferredName":"Percentage Value","preferredDefinition":"Percentage; a fraction or ratio with 100 understood as the denominator.:A numerical quantity measured or assigned or computed.","longName":"C25613:C25712","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Percentage","conceptCode":"C25613","definition":"A fraction or ratio with 100 understood as the denominator.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Value","conceptCode":"C25712","definition":"A numerical quantity measured or assigned or computed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-3E46-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D3B7ECCE-4611-6532-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-02-19","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-02-19","modifiedBy":"KNABLEJ","dateModified":"2022-03-15","changeDescription":"3/15/22 jk added \"Qualified\" RS as part of MCL quarterly content review.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008587","version":"2","longName":"Type of Disease","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2812245","version":"1","longName":"Phase II Breast Cancer","context":"CTEP"},{"publicId":"2811831","version":"1","longName":"Breast","context":"CTEP"}]},{"publicId":"2008589","version":"2","longName":"Type of Category","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811953","version":"1","longName":"Disease Description","context":"CTEP"},{"publicId":"2811959","version":"1","longName":"Patient Char.","context":"CTEP"},{"publicId":"2812156","version":"1","longName":"Breast Cancer DataMart","context":"CTEP"}]},{"publicId":"2008594","version":"2.31","longName":"Trial Type Usages (CDE Disease Committees)","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811914","version":"1","longName":"Adjuvant Breast","context":"CTEP"},{"publicId":"2811917","version":"1","longName":"Advanced Breast","context":"CTEP"},{"publicId":"2811932","version":"1","longName":"Pathology Breast","context":"CTEP"}]},{"publicId":"2008608","version":"1","longName":"Phase","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811891","version":"1","longName":"Phase II","context":"CTEP"}]},{"publicId":"3461586","version":"1","longName":"BOLD:Breast Oncology Local Disease","context":"NCIP","ClassificationSchemeItems":[{"publicId":"3461587","version":"1","longName":"Preoperative Elements","context":"NCIP"},{"publicId":"3461588","version":"1","longName":"General Elements","context":"NCIP"}]},{"publicId":"3886753","version":"1","longName":"General Elements","context":"BOLD","ClassificationSchemeItems":[{"publicId":"3902138","version":"1","longName":"General","context":"BOLD"}]},{"publicId":"3886755","version":"1","longName":"Preoperative Elements","context":"BOLD","ClassificationSchemeItems":[{"publicId":"3902140","version":"1","longName":"Preoperative","context":"BOLD"}]}],"AlternateNames":[{"name":"caBIG","type":"USED_BY","context":"NCIP"},{"name":"BOLD","type":"USED_BY","context":"BOLD"}],"ReferenceDocuments":[{"name":"COMMENT_468","type":"COMMENT","description":"[Note: Use for the following field diameters: 0.59 mm (x25 objective Leitz Orthodox); 0.44 mm (x40 objective Nikon Labophot); 0.63 mm (x40 objective Leitz Diaplan)]","url":null,"context":"CTEP"},{"name":"Percentage of tumor cells tha","type":"Preferred Question Text","description":"Percentage of tumor cells that are mitotic","url":null,"context":"CTEP"},{"name":"2-COMMENT","type":"COMMENT","description":"versioned due to association with wrong VD at time of initial ISO compliance update; correction made; re-released","url":null,"context":"CTEP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"4400B8D8-083D-23FD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-01-18","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-01-18","modifiedBy":"LUY","dateModified":"2013-09-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}